Anatomy and Pathology of the Basal Ganglia

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

1983 • 2,149 citations

Kainic acid as a tool in neurobiology

1978 • 1,314 citations

Molecular Neurobiology of the Mammalian Brain

1987 • 481 citations

A RATIONAL APPROACH FOR ASSESSING THE HYPOTHALAMO-PITUITARY-ADRENAL AXIS

1988 • 420 citations

Human mononuclear phagocyte differentiation antigens. I. Patterns of antigenic expression on the surface of human monocytes and macrophages defined by monoclonal antibodies.

1983 • 402 citations

THE RAPID PRODUCTION OF ACUTE DISSEMINATED ENCEPHALOMYELITIS IN RHESUS MONKEYS BY INJECTION OF HETEROLOGOUS AND HOMOLOGOUS BRAIN TISSUE WITH ADJUVANTS

1947 • 398 citations

Alterations in L-Glutamate Binding in Alzheimer's and Huntington's Diseases

1985 • 334 citations

Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia

1982 • 261 citations

Neurotransmitter receptor alterations in Parkinson's disease

1977 • 251 citations

[3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy

1984 • 215 citations

Sodium dependent [3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinsons disease

1985 • 163 citations

Microglia and the Process of Phagocytosis in Gliomas.

1925 • 149 citations

Distribution of choline acetyltransferase-containing neurons of the hypothalamus

1987 • 144 citations

Lesions of the putamen and dystonia

1984 • 133 citations

Quantitative autoradiography of neurotransmitter receptors in Huntington disease

1982 • 116 citations

Topography of enkephalin, substance P and acetylcholinesterase staining in Huntington's disease striatum

1986 • 109 citations

Brain's Diseases of the Nervous System

1986 • 99 citations

Dopamine D2 receptor density remains constant in treated Parkinson's disease

1986 • 97 citations

Neurotransmitters in the Basal Ganglia

1984 • 93 citations

The Molecules of the Immune System

1985 • 91 citations

L-DOPA reverses the elevated density of D2 dopamine receptors in Parkinson's diseased striatum

1985 • 87 citations

Neurotransmitter receptor alterations in Huntington's disease: Autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes

1985 • 82 citations

Parkinson's disease: decreased density of 3H-imipramine and 3H-paroxetine binding sites in putamen

1986 • 81 citations

Loss of high affinity neurotensin receptors in substantia nigra from parkinsonian subjects

1984 • 71 citations

Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington's disease

1986 • 70 citations

Immunocytochemical studies of substance P and leucine-enkephalin in Huntington's disease

1983 • 68 citations

Microtopography of methionine-enkephalin, dopamine and noradrenaline in the ventral mesencephalon of human control and Parkinsonian brains

1982 • 63 citations

Purification and chemical characterization of the receptor for interleukin 2 from activated human T lymphocytes and from a human T-cell lymphoma cell line.

1984 • 60 citations

Drugs for the Treatment of Parkinson’s Disease

1989 • 51 citations

Regional Distribution of Neurotransmitter Synthesizing Enzymes in the Basal Ganglia of Human Brain

1980 • 46 citations

Loss of substance P and Enkephalin immunoreactivity in the human substantia nigra after striato-pallidal infarction

1984 • 44 citations

Advanced catecholaminergic disturbances in the brain in a case of Wilson's disease

1982 • 36 citations

Methionine-enkephalin and substance P in the basal ganglia of normals, Parkinson patients, Huntington patients, and schizophrenics

1985 • 35 citations

Functional recovery in a rat model of Parkinson's disease following transplantation of cultured human sympathetic neurons

1986 • 35 citations

Studies on neurotransmitter markers and striatal neuronal cell density in Huntington's disease and dentatorubropallidoluysian atrophy

1985 • 33 citations

Opioid peptides in Huntington's disease: Alterations in prodynorphin and proenkephalin system

1986 • 32 citations

Striatal dopamine and homovanillic acid in Huntington's Disease

1986 • 29 citations

Glycine Receptors in the Human Substantia Nigra as Defined by [³H]Strychnine Binding

1982 • 29 citations

Transplantation of cultured fetal human adrenal chromaffin cells to rat brain

1985 • 22 citations

Somatostatin immunoreactivity is reduced in Parkinson's disease dementia with Alzheimer's changes

1986 • 22 citations

Transplantation of cultured human spinal cord cells into the rat motor cortex: use of Phaseolus vulgaris leucoagglutinin as a cell marker

1987 • 22 citations

Adrenergic receptors on cerebral microvessels in control and Parkinsonian subjects

1985 • 14 citations

Characterization of brain proteins reacting in vitro with anti-neuronal antibodies in patients with Huntington's disease

1978 • 13 citations

Excitotoxic amino acids as tools in neurobiology.

1983 • 9 citations